Bioventix PLC (LON:BVXP – Get Free Report)’s share price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 1,595.09 and traded as high as GBX 1,750. Bioventix shares last traded at GBX 1,620, with a volume of 3,393 shares trading hands.
Bioventix Price Performance
The firm has a fifty day simple moving average of GBX 1,592.79 and a two-hundred day simple moving average of GBX 1,621.76. The firm has a market capitalization of £83.60 million, a P/E ratio of 11.39 and a beta of 0.56.
Insider Buying and Selling at Bioventix
In other Bioventix news, insider Bruce Hiscock acquired 534 shares of the company’s stock in a transaction on Wednesday, June 24th. The shares were acquired at an average cost of GBX 1,799 per share, with a total value of £9,606.66. Insiders own 6.23% of the company’s stock.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
See Also
- Five stocks we like better than Bioventix
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
